Role of proinflammatory cytokines in the pathophysiology of osteoarthritis

Ayral, X., Pickering, E. H., Woodworth, T. G., Mackillop, N. & Dougados, M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis—results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 13, 361–367 (2005). 10.1016/j.joca.2005.01.005

[3]

Pozgan, U. et al. Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Biol. Chem. 391, 571–579 (2010). 10.1515/bc.2010.035

[4]

Martel-Pelletier, J., Lajeunesse, D. & Pelletier, J. P. in Arthritis and Allied Conditions. A Textbook of Rheumatology 15th edn (eds Koopman, W. J. & Moreland, L. W.) 2199–2226 (Lippincott Williams & Wilkins, Baltimore, USA, 2005).

[5]

Page Thomas, D. P., King, B., Stephens, T. & Dingle, J. T. In vivo studies of cartilage regeneration after damage induced by catabolin/interleukin-1. Ann. Rheum. Dis. 50, 75–80 (1991). 10.1136/ard.50.2.75

[6]

Henderson, B. & Pettipher, E. R. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor α in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin. Exp. Immunol. 75, 306–310 (1989).

[7]

Clements, K. M. et al. Gene deletion of either interleukin-1β, interleukin-1β-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy. Arthritis Rheum. 48, 3452–3463 (2003). 10.1002/art.11355

[8]

Arend, W. P. Interleukin-1 receptor antagonist. Adv. Immunol. 54, 167–227 (1993). 10.1016/s0065-2776(08)60535-0

[9]

Martel-Pelletier, J. et al. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum. 35, 530–540 (1992). 10.1002/art.1780350507

[10]

Sadouk, M. B. et al. Human synovial fibroblasts coexpress IL-1 receptor type I and type II mRNA. The increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor. Lab. Invest. 73, 347–355 (1995).

[11]

Colotta, F., Dower, S. K., Sims, J. E. & Mantovani, A. The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. Immunol. Today 15, 562–566 (1994). 10.1016/0167-5699(94)90217-8

[12]

Palmer, G. et al. Production of interleukin-1 receptor antagonist by human articular chondrocytes. Arthritis Res. 4, 226–231 (2002). 10.1186/ar411

[13]

Seitz, M. et al. Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes—regulation by IFN-γ and IL-4. J. Immunol. 152, 2060–2065 (1994). 10.4049/jimmunol.152.4.2060

[14]

Alaaeddine, N. et al. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNFα. J. Rheumatol. 24, 1985–1994 (1997).

[15]

Naume, B., Shalaby, R., Lesslauer, W. & Espevik, T. Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells. J. Immunol. 146, 3045–3048 (1991). 10.4049/jimmunol.146.9.3045

[16]

Hohmann, H. P. et al. Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-κB. TNFα is not needed for induction of a biological effect via TNF receptors. J. Biol. Chem. 265, 22409–22417 (1990). 10.1016/s0021-9258(18)45720-1

[17]

Westacott, C. I., Atkins, R. M., Dieppe, P. A. & Elson, C. J. Tumor necrosis factor α receptor expression on chondrocytes isolated from human articular cartilage. J. Rheumatol. 21, 1710–1715 (1994).

[18]

Saklatvala, J. Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322, 547–549 (1986). 10.1038/322547a0

[19]

Goldring, M. B., Fukuo, K., Birkhead, J. R., Dudek, E. & Sandell, L. J. Transcriptional suppression by interleukin-1 and interferon-γ of type II collagen gene expression in human chondrocytes. J. Cell. Biochem. 54, 85–99 (1994). 10.1002/jcb.240540110

[20]

Chadjichristos, C. et al. Sp1 and Sp3 transcription factors mediate interleukin-1β down-regulation of human type II collagen gene expression in articular chondrocytes. J. Biol. Chem. 278, 39762–39772 (2003). 10.1074/jbc.m303541200

[21]

Shakibaei, M., Schulze-Tanzil, G., John, T. & Mobasheri, A. Curcumin protects human chondrocytes from IL-l1β -induced inhibition of collagen type II and β1-integrin expression and activation of caspase-3: an immunomorphological study. Ann. Anat. 187, 487–497 (2005). 10.1016/j.aanat.2005.06.007

[22]

Stöve, J., Huch, K., Günther, K. P. & Scharf, H. P. Interleukin-1β induces different gene expression of stromelysin, aggrecan and tumor-necrosis-factor-stimulated gene 6 in human osteoarthritic chondrocytes in vitro. Pathobiology 68, 144–149 (2000). 10.1159/000055915

[23]

Nietfeld, J. J., Wilbrink, B., Den Otter, W., Huber, J. & Huber-Bruning, O. The effect of human interleukin 1 on proteoglycan metabolism in human and porcine cartilage explants. J. Rheumatol. 17, 818–826 (1990).

[24]

Gouze, J. N. et al. Interleukin-1β down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1β-mediated effects in rat chondrocytes. Arthritis Rheum. 44, 351–360 (2001). 10.1002/1529-0131(200102)44:2<351::aid-anr53>3.0.co;2-m

[25]

Séguin, C. A. & Bernier, S. M. TNFα suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-κB signaling pathways. J. Cell. Physiol. 197, 356–369 (2003). 10.1002/jcp.10371

[26]

Mengshol, J. A., Vincenti, M. P., Coon, C. I., Barchowsky, A. & Brinckerhoff, C. E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor κB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 43, 801–811 (2000). 10.1002/1529-0131(200004)43:4<801::aid-anr10>3.0.co;2-4

[27]

Lefebvre, V., Peeters-Joris, C. & Vaes, G. Modulation by interleukin 1 and tumor necrosis factor α of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim. Biophys. Acta 1052, 366–378 (1990). 10.1016/0167-4889(90)90145-4

[28]

Reboul, P., Pelletier, J. P., Tardif, G., Cloutier, J. M. & Martel-Pelletier, J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J. Clin. Invest. 97, 2011–2019 (1996). 10.1172/jci118636

[29]

Glasson, S. S. et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum. 50, 2547–2558 (2004). 10.1002/art.20558

[30]

Glasson, S. S. et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644–648 (2005). 10.1038/nature03369

[31]

Tortorella, M. D., Malfait, A. M., Deccico, C. & Arner, E. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 9, 539–552 (2001). 10.1053/joca.2001.0427

[32]

Bondeson, J., Wainwright, S. D., Lauder, S., Amos, N. & Hughes, C. E. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res. Ther. 8, R187 (2006). 10.1186/ar2099

[33]

Guerne, P. A., Carson, D. A. & Lotz, M. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J. Immunol. 144, 499–505 (1990). 10.4049/jimmunol.144.2.499

[34]

Lotz, M., Terkeltaub, R. & Villiger, P. M. Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes. J. Immunol. 148, 466–473 (1992). 10.4049/jimmunol.148.2.466

[35]

Villiger, P. M., Terkeltaub, R. & Lotz, M. Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J. Clin. Invest. 90, 488–496 (1992). 10.1172/jci115885

[36]

Alaaeddine, N., Olee, T., Hashimoto, S., Creighton-Achermann, L. & Lotz, M. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum. 44, 1633–1643 (2001). 10.1002/1529-0131(200107)44:7<1633::aid-art286>3.0.co;2-z

[37]

Afonso, V., Champy, R., Mitrovic, D., Collin, P. & Lomri, A. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine 74, 324–329 (2007). 10.1016/j.jbspin.2007.02.002

[38]

Mathy-Hartert, M. et al. Interleukin-1β and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: a possible explanation for oxidative stress generation. Osteoarthritis Cartilage 16, 756–763 (2008). 10.1016/j.joca.2007.10.009

[39]

Scott, J. L. et al. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann. Rheum. Dis. 69, 1502–1510 (2010). 10.1136/ard.2009.119966

[40]

Roman-Blas, J. A. & Jimenez, S. A. NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 14, 839–848 (2006). 10.1016/j.joca.2006.04.008

[41]

Chen, L. X. et al. Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-κBp65-specific siRNA. Osteoarthritis Cartilage 16, 174–184 (2008). 10.1016/j.joca.2007.06.006

[42]

Blom, A. B. et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum. 60, 501–512 (2009). 10.1002/art.24247

[43]

Yuasa, T., Otani, T., Koike, T., Iwamoto, M. & Enomoto-Iwamoto, M. Wnt/β-catenin signaling stimulates matrix catabolic genes and activity in articular chondrocytes: its possible role in joint degeneration. Lab. Invest. 88, 264–274 (2008). 10.1038/labinvest.3700747

[44]

Lane, N. E., Nevitt, M. C., Lui, L. Y., de Leon, P. & Corr, M. Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women. Arthritis Rheum. 56, 3319–3325 (2007). 10.1002/art.22867

[45]

Fahmi, H., Pelletier, J. P. & Martel-Pelletier, J. PPARg ligands as modulators of inflammatory and catabolic responses in arthritis. An overview. J. Rheumatol. 29, 3–14 (2002).

[46]

Kobayashi, T. et al. Pioglitazone, a peroxisome proliferator-activated receptor γ agonist, reduces the progression of experimental osteoarthritis in guinea pigs. Arthritis Rheum. 52, 479–487 (2005). 10.1002/art.20792

[47]

Boileau, C. et al. The peroxisome proliferator-activated receptor γ agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and catabolic pathways. Arthritis Rheum. 56, 2288–2298 (2007). 10.1002/art.22726

[48]

Kobayashi, M. et al. Role of interleukin-1 and tumor necrosis factor α in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum. 52, 128–135 (2005). 10.1002/art.20776

[49]

Caron, J. P. et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum. 39, 1535–1544 (1996). 10.1002/art.1780390914

[50]

Pelletier, J. P. et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum. 40, 1012–1019 (1997). 10.1002/art.1780400604

Showing 50 of 120 references

Cited By

2,292

Acupuncture with near-infrared irradiation using needles loaded with curcumin–polydopamine film attenuates papain-induced knee osteoarthritis in rats

Hong-zhong Xi, Xiao-xue Tan · 2026

Journal of Integrative Medicine

Dendrophenol Mitigates Inflammatory Sickness Behaviors and Maintains CNS Function in Murine Models

Hasriadi Hasriadi, Peththa Wadu Dasuni Wasana · 2026

Medicine in Drug Discovery

BMP-7 modified exosomes derived from synovial mesenchymal stem cells attenuate osteoarthritis by M2 polarization of macrophages

Weixue Sun, Shaozheng Qu · 2023

Heliyon

Structural characterization and anti-inflammatory activity of polysaccharides from Astragalus membranaceus

Guangming Chen, Nan Jiang · 2023

International Journal of Biological...

The potential roles of JAK/STAT signaling in the progression of osteoarthritis

Qingluo Zhou, Qun Ren · 2022

Frontiers in Endocrinology

Resveratrol protection against IL-1β-induced chondrocyte damage via the SIRT1/FOXO1 signaling pathway

ChuanCai Liang, Hengte Xing · 2022

Journal of Orthopaedic Surgery and...

Low-dose irradiation could mitigate osteoarthritis progression via anti-inflammatory action that modulates mitochondrial function

Byoung Hyuck Kim, Hyun Cheol Bae · 2022

Radiotherapy and Oncology

Mammalian Transient Receptor Potential TRPA1 Channels: From Structure to Disease

Karel Talavera, Justyna B. Startek · 2020

Physiological Reviews

Metrics

2,292

Citations

120

References

Details

Published: Nov 30, 2010
Vol/Issue: 7(1)
Pages: 33-42
License: View

Authors

M

Mohit Kapoor

a Arthritis Program University Health Network, Toronto, Ontario, Canada; b Krembil Research Institute, University Health Network, Toronto, Ontario, Canada

J

Johanne Martel-Pelletier

Osteoarthritis Research Unit, Centre de recherche L.-C. Simard, CHUM , Campus Notre-Dame

D

Daniel Lajeunesse

J

Jean-Pierre Pelletier

Osteoarthritis Research Unit, Centre de recherche L.-C. Simard, CHUM , Campus Notre-Dame; Rheumatic Disease Unit, University of Montreal , Montreal ,

H

Hassan Fahmi

Cite This Article

Mohit Kapoor, Johanne Martel-Pelletier, Daniel Lajeunesse, et al. (2010). Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nature Reviews Rheumatology, 7(1), 33-42. https://doi.org/10.1038/nrrheum.2010.196

Role of proinflammatory cytokines in the pathophysiology of osteoarthritis

You May Also Like